Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-042812

EVP & Chief Commercial Officer sold 1,009 shares at an average $94.82 ($95,670)

From the SEC's structured data for this filing

Trades in this filing

Harris Erik · EVP & Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-19 Sale : show line 1 in the form −437 $94.63 $41,353 26,280 D
2021-06-21 Sale : show line 2 in the form −572 $94.96 $54,317 25,708 D
Open-market sales · 1,009 sh · avg $94.82 · $95,670
Loading xslF345X03/doc4.xml…